Compare NSPR & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | KOSS |
|---|---|---|
| Founded | 2005 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 32.8M |
| IPO Year | 2009 | 1994 |
| Metric | NSPR | KOSS |
|---|---|---|
| Price | $0.73 | $3.30 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 336.1K | 24.0K |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.56 |
| EPS | N/A | ★ N/A |
| Revenue | $2,310,000.00 | ★ $13,020,773.00 |
| Revenue This Year | $9.14 | N/A |
| Revenue Next Year | $105.44 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $0.43 | $2.93 |
| 52 Week High | $2.22 | $5.06 |
| Indicator | NSPR | KOSS |
|---|---|---|
| Relative Strength Index (RSI) | 59.13 | 42.61 |
| Support Level | $0.66 | $2.93 |
| Resistance Level | $0.77 | $4.14 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 74.86 | 42.26 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.